News (Life Sciences & Healthcare)

04-Dec-2009  |  Life Sciences & Healthcare

Taylor Wessing advises Health Investment Holdings Limited on multi-million pound fundraising

European law firm Taylor Wessing LLP has advised independent hospital operator Health Investment Holdings Limited (HIHL) on its ... by Howard Palmer more

09-Jul-2009  |  Inward Investment, Life Sciences & Healthcare, Technology

Taylor Wessing acts for Vivacta on a $4.5 million funding round

Taylor Wessing's award-winning Technology and Inward Investment group has acted for UK medtech business, Vivacta Limited, on a ... by Simon Walker more

12-May-2009  |  Competition, EU & Trade, Intellectual Property, Life Sciences & Healthcare, Litigation & Dispute Resolution, Media & Entertainment, Technology

Taylor Wessing launches its second Global Intellectual Property Index

With the value of many tangible assets, in particular real estate, falling in the current economic climate, there's a growing ... by Roland Mallinson more

07-May-2009  |  Intellectual Property, Life Sciences & Healthcare

Taylor Wessing LLP advises Oxford BioMedica on a new collaboration with Sanofi-Aventis

Leading law firm Taylor Wessing LLP has advised Oxford BioMedica (LSE: OXB) on the negotiation of a new collaboration to develop ... by Malcolm Bates, Loretta Pugh, Tim Worden more

14-Oct-2008  |  Intellectual Property, Life Sciences & Healthcare

Les Laboratoires Servier v Apotex [2008] EWHC (Ch) 2347

Judgment on the damages enquiry in Les Laboratoires Servier -v- Apotex was handed down in the Patents Court of the High Court on ... more

13-Oct-2008  |  Intellectual Property, Life Sciences & Healthcare, Technology

Taylor Wessing advises Innate Pharma on the in-licence of a phase 1 monoclonal antibody from Novo Nordisk

Taylor Wessing's Life Sciences & Healthcare Group has advised Innate Pharma (IPH) on an agreement with Novo Nordisk, in which ... more

04-Sep-2008  |  Life Sciences & Healthcare

Taylor Wessing advises Asterand plc on licence agreement with Allergan Inc

Taylor Wessing's Life Sciences & Healthcare Group has advised new client Asterand plc, a leading global provider of human ... more

03-Sep-2008  |  Life Sciences & Healthcare

Taylor Wessing advises Biota on RSV collaboration and licence agreement

Taylor Wessing's Life Sciences & Healthcare Group has advised new client Biota Holdings Limited, a leading anti-infective ... more

08-Jul-2008  |  Corporate, Life Sciences & Healthcare, Tax, Technology

Taylor Wessing advises NovaThera on £30m merger with MedCell

Taylor Wessing LLP has advised NovaThera on their merger with MedCell, to create a new UK company specialising in musculoskeletal ... more

02-May-2008  |  China Group, Intellectual Property, Life Sciences & Healthcare, Media & Entertainment, Technology, The Middle East

Comprehensive ranking of the world's IP jurisdictions

For a detailed breakdown of the IP Index including rankings, country analysis and commentary on the findings, rationale and ... more

10-Apr-2008  |  Intellectual Property, Life Sciences & Healthcare

Taylor Wessing scoops MIP award for European Life Sciences IP Firm of the Year

Taylor Wessing was voted European Life Sciences IP Firm of the Year at the third annual Managing Intellectual Property Global ... more

02-Jan-2008  |  Corporate, Intellectual Property, Life Sciences & Healthcare

Taylor Wessing advises Fovea Pharmaceuticals on its €30m second financing round

Fovea Pharmaceuticals SA, a biomedical and technological company specialising in the development of innovative drug therapy for ... more

05-Dec-2007  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advises Vivacta on £6 million Series B fundraising

Taylor Wessing in London has acted for Vivacta Limited on a £6 million Series B fundraising round. European Venture Capital firms ... more

05-Dec-2007  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advises Vivacta on £6 million Series B fundraising

CLIENTVivacta Limited VALUE£6 millionTRANSACTIONSeries B fundraising roundDESCRIPTIONTaylor Wessing in London has acted for ... more

11-Oct-2007  |  Intellectual Property, Life Sciences & Healthcare

Taylor Wessing is the exclusive European legal sponsor of the 15th Annual BioPartnering Europe Conference

Taylor Wessing is the exclusive European legal sponsor of the 15th Annual BioPartnering Europe (BPE) Conference, on 7-9 October ... more

20-Jul-2007  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advises Vétoquinol on a €250 million IPO deal

CLIENTVétoquinolVALUE€250 millionTRANSACTIONIPODESCRIPTIONAdvised the underwriter Oddo Corporate Finance on the IPO on the French ... more

13-Apr-2007  |  Corporate, Intellectual Property, Life Sciences & Healthcare, Technology

Taylor Wessing advises Innate Pharma S.A. on its recent in-licensing agreement with Cancer Research Technology Limited

CLIENTInnate Pharma SAVALUENot disclosedTRANSACTIONCollaboration and licensing dealDESCRIPTIONAdvised Innate Pharma S.A. on its ... more

30-Mar-2007  |  Corporate, Intellectual Property, Life Sciences & Healthcare

Taylor Wessing advises Oxford BioMedica on global licensing agreement with Sanofi-aventis

Taylor Wessing advised Oxford BioMedica (LSE: OXB) and Sanofi-Aventis (EURONEXT: SAN; NYSE: SNY) on an exclusive global licensing ... more

30-Mar-2007  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advises Oxford BioMedica on global licensing agreement with sanofi-aventis

CLIENTOxford BioMedicaVALUE€518 million (~US$690 million)TRANSACTIONGlobal licensing agreement DESCRIPTIONTaylor Wessing advised ... more

26-Mar-2007  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advises on €9 million subscription and placing for AIM-listed company, Arthro Kinetics plc

Taylor Wessing advised on €9 million subscription and placing for Arthro Kinetics plc, an orthopaedics company dedicated to ... more

26-Mar-2007  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advises on €9 million subscription and placing for AIM-listed company, Arthro Kinetics plc

CLIENTArtho KineticsVALUE€9 millionTRANSACTIONShares subscription and placingDESCRIPTIONTaylor Wessing advised on €9 million ... more

23-Jan-2007  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advises the Debiopharm Group on an exclusive agreement with Cambridge Antibody Technology

CLIENTDebiopharm GroupVALUETransaction ongoingTRANSACTIONLicensing dealDESCRIPTIONAdvised Debiopharm Group on an exclusive ... more

13-Jan-2007  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advises UCB on an expanded product license agreement with Jazz Pharmaceuticals

CLIENTUCBVALUETransaction ongoingTRANSACTIONLicensing dealDESCRIPTIONAdvising UCB on an expanded product license agreement for ... more

04-Jan-2007  |  Corporate, Finance, Life Sciences & Healthcare

Taylor Wessing advises Synergy Healthcare plc on its £181 million takeover offer for Isotron plc

Taylor Wessing is advising Synergy Healthcare plc, the AIM-quoted healthcare services provider, on its recommended, increased ... more

17-Nov-2006  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advises Apax Partners and Merlin Biosciences on a $35 million private equity deal

CLIENTApax Partners and Merlin BiosciencesVALUE$35 millionTRANSACTIONPrivate equity financingDESCRIPTIONAdvised Apax Partners ... more

17-Oct-2006  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advises Neurotech France SA in completing a flip transaction into the US

CLIENTNeurotech Pharmaceuticals IncVALUENot disclosedTRANSACTIONRestructuringDESCRIPTIONAdvised Neurotech France SA and its ... more

06-Oct-2006  |  Intellectual Property, Life Sciences & Healthcare, Real Estate

Taylor Wessing represents the "Men in Scarlet" on Royal Hospital Chelsea's new Infirmary

Taylor Wessing advised the Royal Hospital Chelsea on the construction contract to rebuild its new infirmary; the first stage of a ... more

10-Apr-2006  |  Intellectual Property, Life Sciences & Healthcare

Taylor Wessing advises Innate Pharma on major partnership with Novo Nordisk

Taylor Wessing advised Innate Pharma, the Marseille-based biotechnology company, on a major partnership with Novo Nordisk, the ... more

08-Mar-2006  |  Corporate, Employment & Pensions, Intellectual Property, Life Sciences & Healthcare

Taylor Wessing advises PanOpSys Limited on a $5.25 million Series A funding with Quester

The venture capital group at European law firm, Taylor Wessing, has advised PanOpSys Limited, a medical diagnostics company ... more

16-Feb-2006  |  Corporate, Intellectual Property, Life Sciences & Healthcare, Technology

Taylor Wessing advises Bayer Healthcare AG in a divestment of animal health biological vaccines to Intervet

CLIENTBayer Healthcare AGVALUENot disclosedTRANSACTIONM & ADESCRIPTIONAdvised Bayer Healthcare AG on the divestment of the ... more

25-Jul-2005  |  Corporate, Intellectual Property, Life Sciences & Healthcare, Tax

Taylor Wessing advises Xention Discovery Ltd on its £11m venture capital funding

Taylor Wessing's Cambridge office has advised Xention Discovery Ltd, an emerging pharmaceutical company specialising in ion ... more

25-Jul-2005  |  Corporate, Intellectual Property, Life Sciences & Healthcare, Tax

Taylor Wessing advises Xention Discovery Ltd on its £11m venture capital funding

CLIENTXention Discovery LtdDEAL VALUE£11mTRANSACTIONVenture Capital fundingDESCRIPTIONTaylor Wessing's Cambridge office has ... more

28-Jun-2005  |  Corporate, Employment & Pensions, Life Sciences & Healthcare, Technology

Taylor Wessing advises on £4m spinal investment

Taylor Wessing advised FNI Venture Capital on its investment of £4m in a second institutional financing round for Ranier ... more

28-Jun-2005  |  Corporate, Employment & Pensions, Life Sciences & Healthcare, Technology

Taylor Wessing advises on £4m spinal investment

CLIENTFNI Venture CapitalVALUE£4mTRANSACTIONFundraisingDESCRIPTIONTaylor Wessing has advised FNI Venture Capital on its ... more

27-Jun-2005  |  Corporate, Life Sciences & Healthcare, Technology

Taylor Wessing advises on Europe's largest venture capital fund raising this year

Taylor Wessing has acted for MPM Capital, a global investment firm focused solely on investing in life sciences in its role as ... more

27-Jun-2005  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advises on Europe's largest venture capital fund raising this year

CLIENTMPM CapitalVALUE$59.8mTRANSACTIONFundraisingDESCRIPTIONTaylor Wessing has acted for MPM Capital, a global investment firm ... more

07-Jun-2005  |  Corporate, Employment & Pensions, Intellectual Property, Life Sciences & Healthcare, Real Estate, Tax

Taylor Wessing advises Spain's largest cosmetic surgery group on Ultralase Limited acquisition

Taylor Wessing has acted for Corporación Dermoestética SA, the Spanish cosmetic surgery group, on its acquisition of all the ... more

25-Apr-2005  |  Employment & Pensions, Hotels, Intellectual Property, Life Sciences & Healthcare, Litigation & Dispute Resolution, Real Estate

Five new partners at Taylor Wessing

Taylor Wessing is pleased to announce the appointment of five new partners in the UK office with effect from 1 May 2005. This ... more

03-Mar-2005  |  Corporate, Life Sciences & Healthcare, Technology

Taylor Wessing advises Sphere Medical Holdings

Taylor Wessing's Cambridge office has advised Sphere Medical Holding Limited on a £4 million series of technology funding ... more

03-Mar-2005  |  Corporate, Intellectual Property, Life Sciences & Healthcare, Tax, Technology

Taylor Wessing's Cambridge office advises on a £20m double act of financing rounds

Taylor Wessing's Cambridge office has advised on a series of technology funding deals for clients ACT Venture Capital and Sphere ... more

26-Jan-2005  |  Corporate, Intellectual Property, Life Sciences & Healthcare, Technology

Taylor Wessing advises First Cambridge Gateway on a £3.2m financing round of DanioLabs

Taylor Wessing advised First Cambridge Gateway Fund on a £3.2m financing round of DanioLabs, the Cambridge-based biotechnology ... more

18-Jan-2005  |  Corporate, Employment & Pensions, Intellectual Property, Life Sciences & Healthcare, Technology

Taylor Wessing advises Advent Venture Partners and Scottish Equity Partners on investment in Rhytec Ltd

Taylor Wessing advises Advent Venture Partners and Scottish Equity Partners on their investment of up to £8 million in Rhytec ... more

18-Jan-2005  |  Corporate, Employment & Pensions, Intellectual Property, Life Sciences & Healthcare, Real Estate

Taylor Wessing advises Paradigm Therapeutics Limited on its merger with Amedis Pharmaceuticals Limted

Taylor Wessing advises Paradigm Therapeutics Ltd on its merger with Amedis Pharmaceuticals Ltd, a medical chemistry and drug ... more

04-Nov-2004  |  Corporate, Employment & Pensions, Intellectual Property, Life Sciences & Healthcare, Private Capital, Real Estate, Tax

Taylor Wessing advise on the sale of DNA Research Innovations Ltd for up to $65 million to Invitrogen Corporation

Taylor Wessing has advised the shareholders of DNA Research Innovations Ltd on its sale to NASDAQ-listed Invitrogen Corporation, ... more

26-Mar-2004  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advised Acolyte Biomedica on £3.7 million funding to launch revolutionary tests to combat superbug

Taylor Wessing advised Acolyte Biomedica Ltd, the UK-based developer of microbiology test systems, on securing £3.7 million in ... more